Terns Pharmaceuticals, Inc. (TERN)
52.79
+0.07
(+0.13%)
USD |
NASDAQ |
Apr 01, 16:00
52.74
-0.05
(-0.09%)
After-Hours: 20:00
Terns Pharmaceuticals Research and Development Expense (TTM) : 77.89M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Merck & Co., Inc. | 12.71B |
| Corcept Therapeutics, Inc. | 254.91M |
| Cogent Biosciences, Inc. | 265.16M |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| ADMA Biologics, Inc. | 4.761M |